Profile data is unavailable for this security.
About the company
908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.
- Revenue in USD (TTM)52.69m
- Net income in USD-37.99m
- Incorporated2012
- Employees230.00
- Location908 Devices Inc.645 Summer StreetBOSTON 02210United StatesUSA
- Phone+1 (978) 729-4478
- Fax+1 (302) 655-5049
- Websitehttps://908devices.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LENSAR Inc | 45.12m | -12.56m | 85.67m | 130.00 | -- | 3.60 | -- | 1.90 | -1.11 | -1.11 | 3.92 | 3.24 | 0.6806 | 1.25 | 9.08 | 347,107.70 | -18.94 | -30.97 | -22.49 | -36.94 | 49.87 | 51.04 | -27.83 | -52.30 | 2.15 | -- | 0.00 | -- | 19.25 | 11.57 | 27.77 | -- | -42.91 | -- |
| electroCore, Inc. | 21.28m | -14.23m | 86.97m | 68.00 | -- | 7.58 | -- | 4.09 | -2.19 | -2.19 | 3.25 | 1.78 | 1.16 | 1.41 | 54.85 | 312,955.90 | -77.78 | -70.73 | -125.05 | -88.96 | 83.61 | 75.81 | -66.84 | -352.82 | 2.12 | -- | 0.00 | -- | 86.57 | 74.42 | 15.02 | -- | -5.88 | -- |
| Edap Tms SA (ADR) | 66.50m | -21.08m | 95.17m | 307.00 | -- | 1.86 | -- | 1.43 | -0.5685 | -0.5685 | 1.79 | 1.38 | 0.6992 | 2.37 | 3.42 | 216,625.80 | -22.16 | -6.62 | -31.50 | -9.22 | 40.34 | 43.23 | -31.69 | -9.59 | 1.80 | -- | 0.0599 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
| Fonar Corp | 102.89m | 9.91m | 100.86m | 520.00 | 10.46 | 0.6077 | 4.48 | 0.9804 | 1.44 | 1.44 | 15.02 | 24.73 | 0.496 | 21.85 | 1.37 | 197,855.90 | 6.80 | 7.30 | 7.09 | 7.87 | 43.87 | 47.13 | 13.70 | 14.50 | 7.71 | -- | 0.0047 | -- | 4.30 | 3.36 | 12.58 | -7.16 | -25.07 | -- |
| Sensus Healthcare Inc | 36.37m | 6.65m | 110.95m | 35.00 | 16.63 | 2.10 | 16.16 | 3.05 | 0.4072 | 0.4072 | 2.23 | 3.23 | 0.6601 | 1.10 | 2.65 | 1,039,057.00 | 12.06 | 10.29 | 13.25 | 12.14 | 60.23 | 62.85 | 18.27 | 15.29 | 8.20 | -- | 0.00 | -- | -45.20 | -1.58 | -98.00 | -- | -23.16 | -- |
| Harvard Bioscience, Inc. | 101.13m | -10.68m | 112.08m | 391.00 | -- | 1.67 | -- | 1.11 | -0.2471 | -0.2471 | 2.35 | 1.54 | 0.7441 | 1.64 | 6.88 | 258,631.70 | -7.86 | -3.29 | -9.44 | -3.89 | 58.39 | 56.67 | -10.56 | -4.57 | 0.9416 | -1.31 | 0.3467 | -- | -0.9573 | -1.45 | 64.11 | -- | 18.10 | -- |
| TELA Bio Inc | 64.74m | -42.11m | 112.78m | 227.00 | -- | 26.44 | -- | 1.74 | -1.71 | -1.71 | 2.64 | 0.1163 | 0.8376 | 1.48 | 7.62 | 285,215.80 | -54.48 | -52.00 | -66.54 | -60.95 | 68.61 | 65.32 | -65.04 | -107.65 | 2.52 | -8.69 | 0.9343 | -- | 41.13 | 47.85 | -5.35 | -- | -17.12 | -- |
| 908 Devices Inc. | 52.69m | -37.99m | 123.72m | 230.00 | -- | 0.7907 | -- | 2.35 | -1.15 | -1.15 | 1.60 | 4.52 | 0.2511 | 1.54 | 4.95 | 229,069.60 | -18.11 | -14.16 | -20.12 | -15.35 | 52.32 | 53.02 | -72.10 | -64.25 | 4.23 | -- | 0.00 | -- | 7.21 | 17.89 | -8.45 | -- | 22.98 | -- |
| KORU Medical Systems Inc | 30.82m | -11.76m | 131.60m | 82.00 | -- | 7.03 | -- | 4.27 | -0.2574 | -0.2574 | 0.6742 | 0.4082 | 0.9737 | 2.94 | 6.50 | 375,817.30 | -37.15 | -17.60 | -43.48 | -20.29 | 62.49 | 59.44 | -38.16 | -21.70 | 3.27 | -- | 0.0195 | -- | 2.23 | 10.44 | -58.65 | -- | 11.10 | -- |
| Pro-Dex Inc | 56.80m | 5.21m | 139.11m | 148.00 | 27.89 | 4.56 | 21.78 | 2.45 | 1.53 | 1.53 | 16.34 | 9.36 | 1.09 | 2.48 | 4.64 | 383,770.30 | 10.03 | 12.33 | 12.35 | 15.30 | 28.25 | 31.26 | 9.17 | 12.13 | 1.94 | 5.31 | 0.304 | 0.00 | 16.83 | 14.66 | -69.93 | -12.47 | -6.80 | -- |
| Myomo Inc | 25.24m | -8.38m | 145.39m | 101.00 | -- | 15.66 | -- | 5.76 | -0.2294 | -0.2294 | 0.6847 | 0.3072 | 1.51 | 3.11 | 8.08 | 249,892.40 | -50.25 | -81.78 | -81.40 | -115.27 | 70.03 | 68.50 | -33.22 | -85.76 | 1.62 | -- | 0.00 | -- | 23.70 | 51.09 | 24.00 | -- | 2.82 | -- |
| Acme United Corp | 190.49m | 19.52m | 153.38m | 645.00 | 8.41 | 1.44 | 7.11 | 0.8052 | 4.94 | 4.94 | 46.90 | 28.77 | 1.18 | 2.09 | 5.84 | 295,331.70 | 12.13 | 7.09 | 14.25 | 8.29 | 39.37 | 35.72 | 10.25 | 5.50 | 1.91 | 7.06 | 0.2337 | 18.81 | -1.27 | 6.88 | 486.31 | 31.08 | 9.02 | 4.84 |
| EUDA Health Holdings Ltd | 3.81m | -17.99m | 154.21m | 106.00 | -- | -- | -- | 40.46 | -0.4821 | -0.4451 | 0.1487 | -0.1685 | 1.86 | -- | 7.21 | 35,957.55 | -876.41 | -- | -- | -- | 22.05 | -- | -472.08 | -- | -- | -43.68 | -- | -- | -1.54 | -- | 66.17 | -- | -- | -- |
| Cibus Inc | 2.96m | -291.86m | 155.18m | 183.00 | -- | 0.4488 | -- | 52.41 | -16.39 | -16.39 | 0.1545 | 11.75 | 0.0043 | -- | 3.09 | 16,180.33 | -53.70 | -86.28 | -64.26 | -96.45 | -- | -- | -12,400.74 | -792.07 | -- | -2.66 | 0.0032 | -- | 1,057.33 | 50.41 | -1,484.44 | -- | 18.53 | -- |
| Akoya Biosciences Inc | 93.22m | -60.35m | 156.91m | 330.00 | -- | 7.05 | -- | 1.68 | -1.22 | -1.22 | 1.89 | 0.4498 | 0.5605 | 1.93 | 6.34 | 282,472.70 | -36.29 | -- | -45.98 | -- | 57.57 | -- | -64.74 | -- | 1.98 | -8.00 | 0.7755 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Stereotaxis Inc | 23.75m | -22.08m | 158.31m | 122.00 | -- | 13.67 | -- | 6.67 | -0.265 | -0.265 | 0.285 | 0.202 | 0.5632 | 1.14 | 5.04 | 194,639.30 | -49.21 | -25.02 | -71.93 | -34.12 | 59.28 | 67.57 | -87.38 | -41.90 | 1.53 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
Data as of Nov 08 2024. Currency figures normalised to 908 Devices Inc.'s reporting currency: US Dollar USD
38.24%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| ARK Investment Management LLCas of 30 Sep 2024 | 3.22m | 9.29% |
| Columbia Management Investment Advisers LLCas of 30 Jun 2024 | 1.88m | 5.43% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 1.82m | 5.25% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 1.49m | 4.29% |
| AWM Investment Co., Inc.as of 30 Jun 2024 | 1.01m | 2.92% |
| Fred Alger Management LLCas of 30 Jun 2024 | 1.01m | 2.90% |
| Granahan Investment Management, LLCas of 30 Jun 2024 | 919.63k | 2.65% |
| Iron Triangle Partners LPas of 30 Jun 2024 | 728.87k | 2.10% |
| Millennium Management LLCas of 30 Jun 2024 | 618.31k | 1.78% |
| Geode Capital Management LLCas of 30 Jun 2024 | 561.15k | 1.62% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
